Women who have suffered unexplained repeated pregnancy loss (uRPL) have altered perceptions and brain responses to male body odours, in comparison to those with no history of uRPL, suggests a new study published today in eLife.
The results could lead to urgently needed answers for many women who experience repeat miscarriage with no clear underlying explanation.
Around 50% of human conceptions and 15% of human pregnancies result in miscarriage, but only a limited number of these can be explained. Body odour has been linked to many aspects of healthy human reproduction – such as synchrony of menstruation between women who live together, and the influence of body odours of breast-feeding women on the timing of ovulation and menstruation in others.
“Given that sense of smell is associated with human reproduction, we hypothesised that it may also be related to disorders of human reproduction,” explains lead author Liron Rozenkrantz, who was a graduate student at the Azrieli National Institute for Human Brain Imaging and Research, and the Weizmann Institute of Science, Israel, and is now a Postdoctoral Fellow at the Massachusetts Institute of Technology (MIT), Cambridge, US. “We set out to test the hypothesis that perception of smell – known as olfaction – is altered in unexplained pregnancy loss, specifically the smell of body odours.”
The team started by testing a key olfactory function important in reproduction: the ability to identify mates by smell. They offered 33 women with uRPL and the same number of women with no history of uRPL (controls) three body odour sniff jars, containing body odour from their spouse, a non-spouse male and one with no odor. They found that the women with a history of uRPL were twice as likely to correctly identify their spouse than the control women.
To see whether this was because the women with a history of uRPL had a better sense of smell, the team compared their ability to smell a range of different odours, such as peanuts and soap. The women with experience of uRPL were also better at discriminating between the smells, but only marginally.
The researchers next asked whether it was the characteristics of the men’s body odours that made the women who have had uRPL better at identifying their spouse by smell. They asked 36 women (18 who have experienced uRPL) to rate men’s body odours based on intensity, pleasantness, sexual attraction and fertility. Based on these criteria, the uRPL group rated non-spouse body odours lower when compared with the control group.
To look at how these perceptions might be controlled, the team used MRI scans to look at brain structure and function. They found that women with a history of uRPL had smaller olfactory bulbs, which was surprising given their apparent greater ability to perceive and discriminate between different smells. When they measured brain activity while the women watched an emotional film clip, with or without the subliminal presence of a non-spouse male body odour, they found a remarkable response in the hypothalamus region: while body odour increased the hypothalamus activity in women with history of uRPL, it decreased this activity in the control group.
“We have found that women who experience unexplained pregnancy loss are much more likely to recognise their spouse by smell and rate men’s body odour differently than other women,” concludes senior author Noam Sobel, Professor in Neurobiology at the Azrieli National Institute for Human Brain Imaging and Research, and the Weizmann Institute of Science. “We have also found differences in structural and functional brain patterns, which have not been previously associated with unexplained repeat pregnancy loss. We hope our findings will help direct further thinking and research on this condition, which is currently not well understood or managed.”
eLife is a non-profit organisation created by funders and led by researchers. Our mission is to accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours. We work across three major areas: publishing, technology and research culture. We aim to publish work of the highest standards and importance in all areas of biology and medicine, including Neuroscience, while exploring creative new ways to improve how research is assessed and published. We also invest in open-source technology innovation to modernise the infrastructure for science publishing and improve online tools for sharing, using and interacting with new results. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, the Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.
To read the latest Neuroscience research published in eLife, visit https://elifesciences.org/subjects/neuroscience.
About the Weizmann Institute of Science
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.